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Abstract Myocardial ischemic preconditioning (IPC) is a po-
tent endogenous mechanism of cardioprotection against ische-
mia^reperfusion injury. In this study we focused on the second
phase of IPC as the most interesting in terms of therapeutic
implementations. We aimed at the detection of genes, which are
di¡erentially expressed at 16 h after reperfusion. Precondition-
ing of canine myocardium was initiated by 5 min occlusion of
the left anterior descending coronary artery with subsequent
reperfusion. cDNA representational di¡erence analysis in com-
bination with microarray hybridization and reverse transcription
polymerase chain reaction were used to reveal the changes in
gene expression in canine hearts. We found that functionally
related genes for tristetraproline (TTP), selectin E, matrix met-
alloproteinase 9, and tumor necrosis factor-K were highly upre-
gulated at the late phase of IPC. The upregulation of TTP gene
at the late phase of IPC, reported here for the ¢rst time, may
represent a cardioprotective mechanism, which could be a prom-
ising perspective in clinical interventions against ischemia^reper-
fusion injuries of the heart.
0 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Preconditioning of the myocardium with short periods of
sublethal ischemia and intermittent reperfusion renders it
more resistant to a subsequent potentially lethal ischemic in-
sult [1]. The immediate protective e¡ect of myocardial ische-
mic preconditioning (IPC) is transient and is lost over the
ensuing 1^2 h. However, the initial preconditioning stimulus
also initiates a second window of protection (SWOP) that
becomes apparent 12^24 h later and lasts for 3^4 days [2,3].
Unlike early IPC, the SWOP protects not only against myo-
cardial infarction but also against myocardial stunning [3,4].
Because of this, and because of its sustained duration, consid-
erable interest has recently focused on the SWOP and on its
clinical relevance. Once the mechanism of this adaptive alter-
ation is elucidated, it should be possible to exploit it to protect
the ischemic myocardium in patients [5].
The mechanism of SWOP is not clear in detail, but may
involve a complex cascade of cellular events. First, myocardial
ischemia and subsequent reperfusion induce major metabolic
perturbations, which result in a production of chemical sig-
nals, such as nitric oxide, reactive oxygen species, adenosine,
etc., triggering the development of IPC [3]. These initiators
cause an increase in the rate of myocardial protein synthesis.
Whereas in early IPC existing proteins are activated, late
phase requires increased de novo protein synthesis [6]. So
far, attention has focused on a small number of protein prod-
ucts as potential distal mediators of delayed preconditioning.
These include heat shock proteins, inducible nitric oxide syn-
thase, aldose reductase, ATP-sensitive potassium channel, cy-
clo-oxygenase 2, and antioxidant enzymes [3]. The progression
of IPC also involves activation of di¡erent transcription-reg-
ulatory mechanisms (kinase signaling pathways/transcription
factors) and posttranscriptional modulators [7].
It is now evident that SWOP is a complex multi-factor pro-
cess, which probably includes the alteration of many genes at
the RNA level [3]. We used cDNA representational di¡erence
analysis (RDA) to make an inventory of genes up- or down-
regulated at the di¡erent phases of IPC in canine hearts. The
RDA technique o¡ers a means for the identi¢cation of can-
didate genes in a highly speci¢c manner. In the present study,
we focused on di¡erential gene expression during the late
phase of preconditioning. The ultimate goal of our work
was to reveal the genes that may present an interest as poten-
tial pharmacological targets for clinical implementations.
2. Materials and methods
2.1. Materials
IPC was simulated in anesthetized, open-chest dogs. The animals
were subjected to 5 min of coronary occlusion of the left anterior
descending coronary artery perfusing the anterior wall followed either
by 4, 8, or 16 h of reperfusion. In the canine model, even a shorter
(90 s to 2.5 min), single occlusion is capable of preconditioning the
heart [8^10]. Dogs in a second, control group were sham-operated,
but not subjected to coronary occlusion. During the experiments,
systemic hemodynamics was measured regularly. In addition, arterial
blood gases and hematocrit were monitored regularly. Body temper-
ature, which is a major factor for myocardial contractile function, was
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measured periodically, and it was maintained between 37 and 38‡C
with the aid of a heating/cooling table. Following the experimental
protocol, transmural blocks of myocardial tissue from the center of
the anterior wall and the posterior control wall were taken and im-
mediately frozen at 380‡C.
The investigation conforms to the Guide for the Care and Use of
Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996).
2.2. Isolation of RNA from heart tissue and cDNA synthesis
Total RNA from shock-frozen left ventricular myocardium was
extracted using the standard guanidinium thiocyanate method, fol-
lowed by centrifugation in a cesium chloride gradient (Pharmacia
LKB, Freiburg, Germany). Poly(Aþ) RNA was isolated by using
oligo(dT) coupled to magnetic beads (Dynabeads, Dynal, Norway)
according to the manufacturer’s instructions. To overcome individual
alterations in gene expression, mRNA samples from three animals of
the same experimental groups were pooled. Double-stranded cDNA
was synthesized from mRNA by oligo(dT) priming using the Super
Choice cDNA synthesis kit (Invitrogen) as recommended by the man-
ufacturer.
2.3. RDA experiments
RDA was carried out by the protocol of Hubank and Schatz [11]
with slight modi¢cations. Representations were generated after diges-
tion of 1.5 Wg double-stranded cDNA with DpnII restriction enzyme,
ligation of R-Bam adapters (14‡C, 12 h) and ampli¢cation using
R-Bam-24 as a primer (5 min at 72‡C; 20 cycles of 1 min at 95‡C
and 3 min at 72‡C). Puri¢cations were always done with Qiaex spin
columns (Qiagen, Germany); di¡erence products (DP) 1^3 were gen-
erated following a standard protocol [11] with aliquots analyzed by
gel electrophoresis (compare Fig. 1). For generation of the driver
300 Wg of control representation was digested with 750 U of DpnII.
For generation of the tester 10 Wg of representation was digested with
50 U of DpnII and ligated to J-Bgl-24 using J-Bgl-12 as adapter
oligonucleotide.
First subtractive hybridization was done with 40 Wg of digested
driver and 400 ng of tester (1:100 ratio). Subsequent polymerase chain
reactions (PCRs) were done as described in [11] using J-Bgl-24 as
primer, resulting in DP1. Adapters were removed by complete diges-
tion with DpnII before N-Bgl oligomers were ligated.
In subsequent steps the adapters were changed before each round of
RDA (N-Bgl-12/24 for second and J-Bgl-12/24 for third round again)
and using the corresponding 24-mers as PCR primers. Further rounds
of subtraction hybridization and ampli¢cation were done in a similar
manner with tester to driver ratios of 1:800 at the second round and
1:400 000 at the third round of RDA.
Determination of DNA concentration was done by £uorometry.
Cloning of DP3 was in the pGEM-T Easy vector system in Escheri-
chia coli DH10b cells. Individual colonies from the subtracted libraries
were picked into 384-well liquid cultures. Sequencing of the clones
followed standard procedures for the automated sequencer (Applied
Biosystems, USA). BLASTN and BLASTX analyses were used to
screen for nucleotide and protein homologies of the sequences identi-
¢ed [12].
2.4. Microarraying of RDA products
Arrays representing the DP3 clones were produced for back-hybrid-
ization with individual clones to reduce the redundancy within this
library and for back-hybridization with representations of the cDNA
populations. Plasmid inserts of all picked clones were PCR-ampli¢ed
using DP3-speci¢c RDA primer J-Bgl-24. PCR was performed by
adding 0.5 Wl saturated growth liquid culture to 100 Wl PCR reactions
containing 10 mM Tris (pH 9.0), 50 mM KCl, 150 WM dNTP, 3 M
betain, 30 mM cresol red, and 2.0 U Taq DNA polymerase (MBI
Fermentas, Germany) in 96-well plates. Thermal cycling conditions
consisted of an initial denaturation at 95‡C for 3 min, followed by
35 cycles of 95‡C for 1 min and 72‡C for 3 min, with a ¢nal 10 min
extension at 72‡C in PTC100 thermal cycler (MJ Research). Five
microliters of each PCR were examined on an agarose gel. Each
PCR product was puri¢ed by ethanol precipitation. Subsequent spot-
ting on custom polylysine slides was carried out with ESI robotic
spotter (Engineering Services) using betain spotting solution according
to the protocol described by Diehl et al. [13]. PCR products of indi-
vidual clones or RDA amplicons (1 Wg each) were £uorescently la-
beled with either Cy3 or Cy5 dye. Maximum incorporation of £uo-
rescent nucleotide was accomplished with 100 WM dGTP, dTTP and
dATP and 10 WM unlabeled dCTP: dUTP-Cy3 or dUTP-Cy5 (Amer-
sham) was added to a ¢nal concentration of 20 WM and incorporated
into DNA using random primer labeling as per the manufacturer’s
recommendations (MBI Fermentas). Labeled RDA probes were puri-
¢ed through Qiagen columns (Qiagen, Germany), dried in a Speed-
Vac, and resuspended in a total volume of 16 Wl 3Usodium saline
citrate (SSC), 1% sodium dodecyl sulfate (SDS), 5UDenhardt’s solu-
tion, 100 Wg/ml sheared salmon sperm DNA, 50% formamide and
10% dextran sulfate. The probe was denatured in the hybridization
solution at 80‡C for 10 min and applied to the arrayed/denatured slide
at 42‡C for 12 h in a humidi¢ed chamber (Telechem). Hybridized
slides were washed in 2USSC, 0.1% SDS for 5 min at room temper-
ature, and in 0.2USSC for 5 min prior to scanning by laser ScanAr-
ray5000 £uorometer (GSI Lumonics). For comparative hybridizations
with the cDNA representations separate images with 10 Wm per pixel
resolution were captured for each of two £uorophores used. GenePix
ver. 3.0 (Axon Instruments) software was used to quantitate the signal
at each spot. Signal normalization was performed by using internal
standards (canine cyclophilin A and L-actin genes) and external con-
trols prepared from the custom set of non-cross-hybridizing Arabidop-
sis thaliana genomic DNA clones.
2.5. Reverse transcription (RT)-PCR
cDNA samples synthesized from the starting RNA were used as
templates for RT-PCR reactions. Ampli¢cation was performed in
1UPCR bu¡er (50 mM KCl, 10 mM Tris^HCl, 0.1% Triton
X-100), with a total reaction volume of 50 Wl. This contained ¢nal
concentrations of 200 WM of each dNTP, 2.5 mM of MgCl2, 500 WM
of each primer, and 1.5 U/Wl of Taq DNA polymerase (MBI Fermen-
tas). The structures of the primers for the ampli¢cation of the genes
found among RDA di¡erence products were derived from the DNA
sequences obtained by us. The sequences of canine tumor necrosis
factor-K (TNF-K) and cyclophilin A genes were extracted from the
EMBL nucleotide database. Primer pairs were designed using Primer3
Fig. 1. Comparison of the three DPs of the RDA procedure on
2.5% agarose gel. Leftmost lane is GeneRuler1 DNA Ladder
marker (MBI Fermentas) with 100 bp increments (size of the lower
band is 100 bp). Whereas in DP1 a relatively complex DNA can be
seen, a reduction of complexity towards few bands in DP2 and DP3
becomes visible.
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software [14]. The record of primers used in the experiments is given
in Table 1. PCR reactions were performed under conditions in which
the linearity of the ampli¢cation was con¢rmed. The concentration of
cDNA templates in all PCR reactions was equalized. Additionally,
ampli¢cation of the cyclophilin A gene with the same templates served
as an internal reference because it is expressed at a relatively constant
level in virtually all tissues [15]. RT-PCR results were visualized on
agarose gel.
3. Results
To detect genes di¡erentially regulated at the SWOP we
performed cDNA RDA using mRNA isolated 16 h after re-
perfusion as a tester and at 8 h after reperfusion as a driver.
The RDA resulted in a straight reduction of cDNA popula-
tion complexity in each round of subtractive hybridization
and ampli¢cation (Fig. 1). After cloning of DP3, picking of
384 clones and the sequencing of selected clones, 44 DNA
contigs were identi¢ed. The search in public databases re-
sulted in the identi¢cation of 15 di¡erent known genes (of
which three were represented by more than one contig), ¢ve
repetitive sequences, and 16 sequences unidenti¢ed so far
(Table 2).
Di¡erence products representing unique DNA sequences
were PCR-ampli¢ed, spotted onto glass slides, and hybridized
with Cy3/Cy5-labeled amplicons. After subtracting the back-
ground signal and normalization, the spot intensities were
calculated. The genes were considered di¡erentially expressed
if the ratio of the medians (Rm) of Cy3/Cy5 signals of the
corresponding spots were higher than 2.5. Three genes ap-
peared to be highly upregulated: tristetraproline (TTP)
(Rms 8), matrix metalloproteinase-9 (MMP9) (Rms 6), and
selectin E (Rms 7).
To con¢rm the results of microarray hybridization we used
RT-PCR as an independent method of measuring levels of
Table 1
Sequences of the primers used for RT-PCR
Molecule Forward 5PC3P Reverse 5PC3P Product length (bp)
Cyclophylin A agagaagggattcggttacaaag atggtgatcttcttgctggtct 348
Selectin E gttagaacagggattcggagatt acagagagcactcctctggttc 265
TTP ctggtggagagtccaagctgt ggcagagttcggtcttgtactt 262
TNF-K atcatcttctcgaaccccaag ggttgacctttgtctggtagga 272
MMP9 ccccttccttatcaccgacac gatccacggtctgcgtcttc 275
SAA tgacatgagagaagccaactaca agagccaagaggaagctcagt 290
Cysteine dioxygenase ggaggtgaacgtagaggaggt acgtgacagccagacagaagt 347
Metastasis-associated gene (Mta1) gaagctgtgctccggtaccta cccctactgggcatcaagag 213
Phosphoglucomutase-related protein (PGMRP) cctccattcaagtgatgacg tgtatgcagagagctatgagagg 150
Amphiregulin (AR) ggaagaagaagaatccctgtg tttcgttcttcagcttctcct 301
Collagen type IV K 1 chain (COL4A1) tgtatgcagagagctatgagagg cctccattcaagtgatgacg 150
RNA polymerase II subunit agtgcagaccacaccagactac ccttgaagcacccagtacaa 343
Iroquois homeobox protein 3 (Irx3) cctcaagaaggagaacaagatga acttcataaagggtcgggaga 259
Mutant desmin (MUTDESM) gaggagtggtacaagtcgaagg tgtcaacatctgtgtgctgct 202
TIS21 gacccctatgaggtgtcctac ggagactgccatcacatagttt 159
Ran binding protein 13 (RANBP13) ccaacttggatgctgtgtct ttccttcaccatctccttcac 314
Helix-loop-helix protein (Id-2) tccaaataggagattgcgttg tctgtggattcgttgttgttg 284
Table 2
List of the canine sequences identi¢ed among the RDA di¡erence productsa








1 Canis familiaris serum amyloid A protein (SAA) M59175 410 e-112 96 BQ172873
2 Homo sapiens cysteine dioxygenase D85777 298 2e-78 92 BQ172874
3 Homo sapiens metastasis-associated gene (Mta1) U35113 430 e-118 91 BQ172875
4 Homo sapiens phosphoglucomutase-related protein (PGMRP) L40933 302 1e-79 91 BQ172876
5 Bos taurus tristetraproline (TTP) L42319 246 3e-63 91 BQ172881
6 Canis familiaris E-selectin L23087 283 2e-74 95 BQ172882
7 Homo sapiens amphiregulin (AR) M30704 344 2e-92 86 BQ172885
8 Canis familiaris collagen type IV K 1 chain (COL4A1) U50933 687 0.0 98 BQ172889
9 Mus musculus RNA polymerase II subunit D85818 163 5e-38 93 BQ172896
10 Canis familiaris MMP9 AF169244 678 0.0 98 BQ172897
11 Mus musculus iroquois homeobox protein 3 Y15001 186 3e-45 86 BQ172898
12 Homo sapiens mutant desmin (MUTDESM) AF137053 276 4e-72 89 BQ172909
13 Homo sapiens helix-loop-helix protein (Id-2) M97796 60 5e-07 85 BQ172892
14 Mus musculus TIS21 M64292 301 5e-80 92 BQ172883
15 Homo sapiens Ran binding protein 13 (RANBP13) AF267987 280 4e-73 94 BQ172907
16 Repetitive sequences Accession numbersb : BQ172877, BQ172879, BQ172886,
BQ172891, BQ172906
17 Sequences without homology in GenBank database Accession numbersb : BQ172878, BQ172880, BQ172884,
BQ172887, BQ172888, BQ172890, BQ172893, BQ172894,
BQ172895, BQ172899, BQ172901, BQ172902, BQ172903,
BQ172904, BQ172905, BQ172908
aIDs of nearest homologs from GenBank database are given. Sequences with E values more than 0.005 were taken as unidenti¢ed. The inter-
pretation of bit scores and E values is given in BLAST tutorial available at http://www.ncbi.nlm.nih.gov/Education/BLASTinfo/Blast_out-
put.html#Scores.
bAccession numbers of the sequences of RDA di¡erential products in dbEST GenBank database.
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gene expression. RT-PCR has an important advantage in
comparison to microarray hybridization because it makes it
possible not only to detect relative changes in gene expression
between two samples, but also to track the level of expression
over a time course. We analyzed the expression of 15 identi-
¢ed genes in the heart tissue of the experimental animals at 4,
8, and 16 h after reperfusion and in the sham-operated con-
trol. Additionally, TNF-K gene as a crucial regulator was
selected for RT-PCR for the considerations mentioned below.
Each reaction was repeated at least three times to avoid acci-
dental errors. In all cases, TTP, MMP9, selectin E, and TNF-
K genes appeared to be highly overexpressed only at 16 h after
the reperfusion, whereas at the other time points and in con-
trol no upregulation was observed (Fig. 2). Thus, the genes in
focus, identi¢ed by RDA, were clearly con¢rmed as being
di¡erentially regulated by two independent methods. Di¡er-
ential expression of the other genes found among the RDA
products was not con¢rmed by both microarray hybridization
and RT-PCR, although some of them (serum amyloid A pro-
tein (SAA), RNA polymerase II, and collagen IV) were pre-
viously reported as being involved in post-ischemic processes
in myocardium.
4. Discussion
The cDNA RDA technique combined with microarray hy-
bridization allowed us to identify a group of genes which are
highly upregulated at the late phase of IPC (16 h after reper-
fusion). RT-PCR analysis con¢rmed this result and addition-
ally revealed that these genes are not overexpressed either in
the control group of animals, or at the early stages of IPC.
The similarity of expression pro¢les of TTP, selectin E,
MMP9, and TNF-K genes implies their functional interrela-
tions.
Both selectin E and MMP9 are involved in the in£amma-
tory response, which is a common event after myocardial
ischemia^reperfusion [16]. It is manifested by the in£ux of
leukocyte cells into the ischemic region due to activation of
di¡erent signaling pathways and is a prerequisite for myocar-
dium healing and scar formation.
Selectin E is an endothelial-speci¢c cell adhesion molecule
that recognizes carbohydrate ligands on circulation leuko-
cytes. It plays a central role in directing neutrophil tra⁄c
from the bloodstream into sites of in£ammation [17].
MMP9 belongs to a large family of matrix metallopro-
teinases, which are responsible for collagen degradation and
remodeling of the extracellular matrix in a number of phys-
iological processes [18]. Along with some other metallopro-
teinases, MMP9 is activated during in£ammation reaction
[19]. It is produced by polymorphonuclear neutrophils and
has been suggested to facilitate their migration through the
endothelial basement membrane [20].
The expression of both selectin E and MMP9 is regulated
primarily at the transcription level by TNF-K, which is one of
the principal mediators of in£ammatory and apoptosis path-
ways in mammals. Recent experiments with transgenic mice
have demonstrated that cardiac-speci¢c overexpression of
TNF-K causes a robust increase in MMP9 activity in vitro
[21] and in vivo [22,23].
The regulation of the selectin E expression is mediated by
nuclear factor UB (NF-UB), which has three binding sites in
the selectin E proximal promoter region. In endothelial cells,
NF-UB is retained in an inactive complex with cytoplasmic
inhibitor IUB. It was shown that brief exposure of endothelial
cells to TNF-K induces degradation of IUB [24]. Thus, TNF-K
appears to be a principal regulator of selectin E expression.
Despite its pivotal role in the upregulation of MMP9 and
selectin E genes, TNF-K was not found among the DPs in our
RDA experiment. However, the results of RT-PCR suggest
that TNF-K is overexpressed at 16 h after reperfusion. This
re£ects that cDNA RDA cannot detect all genes of interest,
maybe due to ine⁄cient cloning or absence of ampli¢able
cDNA fragments.
Another gene, which we identi¢ed as being overexpressed at
the late phase of IPC, is TTP, also known as TIS11, Nup475
or Zfp36. TTP is the prototype member of zinc ¢nger tran-
scription factors and is widely distributed in many tissues. It
was shown that TTP knockout mice display evidence of
chronic TNF-K excess, and their macrophages hypersecrete
TNF-K [25]. TTP is capable of suppression of TNF-K at the
posttranscriptional level by binding to the AU-rich element of
the TNF-K messenger RNA [26,27]. Another report suggests
that TTP might regulate TNF-K production also at the level
of transcription [28]. TTP is activated by the translocation
from nucleus to cytoplasm. The amount of TTP in the cyto-
plasm is increased by the same stimuli that cause increased
expression of TNF-K in macrophages, thus leading to the
negative feedback loop [26]. This could probably explain the
simultaneous upregulation of TTP and TNF-K in our experi-
ments.
Of special interest is that TTP activity is primarily regulated
by the p38 mitogen-activated protein kinase (p38 MAPK)
system [28^30]. Although p38 MAPK is necessary for the
induction of TTP [29], several lines of evidence exist that
TTP can be deactivated by phosphorylation with p38
MAPK [28,30]. Recent studies revealed that the inhibition
of p38 MAPK substantially reduces myocardial ischemia^re-
perfusion injury [31]. The cardioprotective mechanisms pro-
posed for the explanation of this e¡ect invoke repression of
endothelial adhesion molecule expression and blockade of
Fig. 2. RT-PCR analysis of expression-selected genes. Upregulation
of TTP, TNF-K, selectin E, and MMP9 genes is visible at 16 h after
reperfusion. Constitutively expressed cyclophilin A gene served as
normalization reference. No overexpression of the respective genes
can be seen in the control, neither at 4 nor at 8 h after reperfusion.
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neutrophil accumulation, i.e. the relief of in£ammatory reac-
tion [31].
We assume that the elimination of the posttranscriptional
suppression of TTP achieved by p38 MAPK inhibition could
play an important role in the cardioprotection due to the
ability of TTP to regulate TNF-K expression. Numerous re-
ports indicate that anti-TNF treatment could prevent delete-
rious consequences of myocardial ischemia and reperfusion
(reviewed by Meldrum [32]). On the other hand, several stud-
ies suggested that TNF-K activation might have cardioprotec-
tive e¡ect in the setting of myocardial ischemia mediated
through TNF-induced upregulation of manganese superoxide
dismutase [33,34]. Kurrelmeyer et al. [35] proposed that the
initial short-term activation of TNF-K during myocardial
stress response may be bene¢cial, but this positive e¡ect is
lost if myocardial TNF-K expression becomes sustained and/
or excessive.
In our experiments, the expression of TNF-K highly in-
creased 16 h after reperfusion and probably caused the induc-
tion of the TTP gene. We suppose that such a feedback up-
regulation of the TTP gene may represent a part of the
delayed preconditioning mechanism.
The ability of TTP to attenuate TNF-K activity may allow
the regulation of the downstream in£ammatory genes. We
suggest TTP-mediated modulation of TNF-K expression as a
promising perspective in clinical interventions against ische-
mia^reperfusion injuries of the heart.
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